99 related articles for article (PubMed ID: 20097066)
1. Semi-synthetic aristolactams--inhibitors of CDK2 enzyme.
Hegde VR; Borges S; Pu H; Patel M; Gullo VP; Wu B; Kirschmeier P; Williams MJ; Madison V; Fischmann T; Chan TM
Bioorg Med Chem Lett; 2010 Feb; 20(4):1384-7. PubMed ID: 20097066
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo[3,4-c]pyridazines as novel and selective inhibitors of cyclin-dependent kinases.
Braña MF; Cacho M; García ML; Mayoral EP; López B; de Pascual-Teresa B; Ramos A; Acero N; Llinares F; Muñoz-Mingarro D; Lozach O; Meijer L
J Med Chem; 2005 Nov; 48(22):6843-54. PubMed ID: 16250643
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide hydrazone derivatives as potential agents against A549 lung cancer cells.
Xia Y; Fan CD; Zhao BX; Zhao J; Shin DS; Miao JY
Eur J Med Chem; 2008 Nov; 43(11):2347-53. PubMed ID: 18313806
[TBL] [Abstract][Full Text] [Related]
4. Benzodipyrazoles: a new class of potent CDK2 inhibitors.
D'Alessio R; Bargiotti A; Metz S; Brasca MG; Cameron A; Ermoli A; Marsiglio A; Polucci P; Roletto F; Tibolla M; Vazquez ML; Vulpetti A; Pevarello P
Bioorg Med Chem Lett; 2005 Mar; 15(5):1315-9. PubMed ID: 15713378
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of aristolactams.
Couture A; Deniau E; Grandclaudon P; Rybalko-Rosen H; Léonce S; Pfeiffer B; Renard P
Bioorg Med Chem Lett; 2002 Dec; 12(24):3557-9. PubMed ID: 12443775
[TBL] [Abstract][Full Text] [Related]
6. 4-arylazo-3,5-diamino-1H-pyrazole CDK inhibitors: SAR study, crystal structure in complex with CDK2, selectivity, and cellular effects.
Krystof V; Cankar P; Frysová I; Slouka J; Kontopidis G; Dzubák P; Hajdúch M; Srovnal J; de Azevedo WF; Orság M; Paprskárová M; Rolcík J; Látr A; Fischer PM; Strnad M
J Med Chem; 2006 Nov; 49(22):6500-9. PubMed ID: 17064068
[TBL] [Abstract][Full Text] [Related]
7. 4-(Pyrazol-4-yl)-pyrimidines as selective inhibitors of cyclin-dependent kinase 4/6.
Cho YS; Borland M; Brain C; Chen CH; Cheng H; Chopra R; Chung K; Groarke J; He G; Hou Y; Kim S; Kovats S; Lu Y; O'Reilly M; Shen J; Smith T; Trakshel G; Vögtle M; Xu M; Xu M; Sung MJ
J Med Chem; 2010 Nov; 53(22):7938-57. PubMed ID: 21038853
[TBL] [Abstract][Full Text] [Related]
8. N-heterocyclic derived M1 positive allosteric modulators.
Kuduk SD; Di Marco CN; Cofre V; Pitts DR; Ray WJ; Ma L; Wittmann M; Veng L; Seager MA; Koeplinger K; Thompson CD; Hartman GD; Bilodeau MT
Bioorg Med Chem Lett; 2010 Feb; 20(4):1334-7. PubMed ID: 20097564
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, antiamoebic activity and cytotoxicity of novel series of pyrazoline derivatives bearing quinoline tail.
Hayat F; Salahuddin A; Umar S; Azam A
Eur J Med Chem; 2010 Oct; 45(10):4669-75. PubMed ID: 20696501
[TBL] [Abstract][Full Text] [Related]
11. Structure-based drug design to the discovery of new 2-aminothiazole CDK2 inhibitors.
Vulpetti A; Casale E; Roletto F; Amici R; Villa M; Pevarello P
J Mol Graph Model; 2006 Mar; 24(5):341-8. PubMed ID: 16260160
[TBL] [Abstract][Full Text] [Related]
12. Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors.
Dwyer MP; Paruch K; Alvarez C; Doll RJ; Keertikar K; Duca J; Fischmann TO; Hruza A; Madison V; Lees E; Parry D; Seghezzi W; Sgambellone N; Shanahan F; Wiswell D; Guzi TJ
Bioorg Med Chem Lett; 2007 Nov; 17(22):6216-9. PubMed ID: 17904366
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and SAR of inhibitors of protein kinase CK2: novel tricyclic quinoline analogs.
Haddach M; Pierre F; Regan CF; Borsan C; Michaux J; Stefan E; Kerdoncuff P; Schwaebe MK; Chua PC; Siddiqui-Jain A; Macalino D; Drygin D; O'Brien SE; Rice WG; Ryckman DM
Bioorg Med Chem Lett; 2012 Jan; 22(1):45-8. PubMed ID: 22169261
[TBL] [Abstract][Full Text] [Related]
14. Discovery of indenopyrazoles as EGFR and VEGFR-2 tyrosine kinase inhibitors by in silico high-throughput screening.
Usui T; Ban HS; Kawada J; Hirokawa T; Nakamura H
Bioorg Med Chem Lett; 2008 Jan; 18(1):285-8. PubMed ID: 17983745
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[4,3-c]quinolines, synthesis and specific inhibition of benzodiazepine receptor binding. Note II.
Savini L; Massarelli P; Corti P; Pellerano C; Bruni G; Romeo MR
Farmaco; 1993 Dec; 48(12):1675-86. PubMed ID: 8135991
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of 6-(benzyloxy)-4-methylquinolin-2(1H)-one derivatives as PDE3 inhibitors.
Nikpour M; Sadeghian H; Saberi MR; Nick RS; Seyedi SM; Hosseini A; Parsaee H; Bozorg AT
Bioorg Med Chem; 2010 Jan; 18(2):855-62. PubMed ID: 20005117
[TBL] [Abstract][Full Text] [Related]
17. An efficient tool for identifying inhibitors based on 3D-QSAR and docking using feature-shape pharmacophore of biologically active conformation--a case study with CDK2/cyclinA.
Mascarenhas NM; Ghoshal N
Eur J Med Chem; 2008 Dec; 43(12):2807-18. PubMed ID: 18037537
[TBL] [Abstract][Full Text] [Related]
18. 4-Anilino-7,8-dialkoxybenzo[g]quinoline-3-carbonitriles as potent Src kinase inhibitors.
Berger DM; Dutia M; Birnberg G; Powell D; Boschelli DH; Wang YD; Ravi M; Yaczko D; Golas J; Lucas J; Boschelli F
J Med Chem; 2005 Sep; 48(19):5909-20. PubMed ID: 16161995
[TBL] [Abstract][Full Text] [Related]
19. Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements.
Ameriks MK; Axe FU; Bembenek SD; Edwards JP; Gu Y; Karlsson L; Randal M; Sun S; Thurmond RL; Zhu J
Bioorg Med Chem Lett; 2009 Nov; 19(21):6131-4. PubMed ID: 19773165
[TBL] [Abstract][Full Text] [Related]
20. Non-oxime pyrazole based inhibitors of B-Raf kinase.
Newhouse BJ; Hansen JD; Grina J; Welch M; Topalov G; Littman N; Callejo M; Martinson M; Galbraith S; Laird ER; Brandhuber BJ; Vigers G; Morales T; Woessner R; Randolph N; Lyssikatos J; Olivero A
Bioorg Med Chem Lett; 2011 Jun; 21(11):3488-92. PubMed ID: 21536432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
